Sabrina Dominici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sabrina Dominici has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Boberg
Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
1 shared publication - Andreas Bråve
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet and Swedish Institute for Infectious Disease Control, Stockholm, Sweden
1 shared publication - Britta Wahren
Swedish Institute for Infectious Disease Control and Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden
1 shared publication - Jorma Hinkula
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
1 shared publication - Kristian Hallermalm
Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Mauro Magnani
Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, PU, Italy
1 shared publication
Latest Publications
- Open Access
- 18 April 2007
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 2 (1) , 9
Immunization with HIV protease peptides linked to syngeneic erythrocytes
New potent vaccine adjuvants are desirable for increasing the efficacy of novel vaccine modalities such as DNA and peptides. We therefore tested if syngeneic erythrocytes could serve as delivery vectors for selected HIV peptides and compared the potency of these constructs to immunization with peptides in phosphate buffered saline or in incomplete Freunds adjuvant.
- 18 April 2007
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 2 (1) , 9
Open AccessImmunization with HIV protease peptides linked to syngeneic erythrocytes
New potent vaccine adjuvants are desirable for increasing the efficacy of novel vaccine modalities such as DNA and peptides. We therefore tested if syngeneic erythrocytes could serve as delivery vectors for selected HIV peptides and compared the potency of these constructs to immunization with peptides in phosphate buffered saline or in incomplete Freunds adjuvant.